Trial Profile
Duloxetine for chronic osteoarthritis pain; an important alternative?
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 13 Jan 2022
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Musculoskeletal pain; Pain
- Focus Therapeutic Use
- Acronyms DUO-trial
- 06 Jan 2022 Primary endpoint (The primary outcome of this study will be pain at 3 months measured with the WOMAC pain subscale.) has not been met, according to Results published in the Arthritis and Rheumatology.
- 06 Jan 2022 Results published in the Arthritis and Rheumatology
- 03 Jul 2020 Status changed from recruiting to discontinued.